These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20107294)

  • 1. Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Asia-Pacific.
    Zaninelli A; Hu DY; Kaufholz C; Schwappach D
    Postgrad Med; 2010 Jan; 122(1):108-17. PubMed ID: 20107294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Europe and Latin America.
    Zaninelli A; Kaufholz C; Schwappach D
    Postgrad Med; 2009 Nov; 121(6):44-53. PubMed ID: 19940416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin treatment after myocardial infarction: are health maintenance organization members, women, and the elderly undertreated?
    Hill JW; Roglieri JL; Warburton SW
    Am J Manag Care; 1998 Jan; 4(1):51-8. PubMed ID: 10179906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing of beta-blockers after myocardial infarction: a preliminary study of physician motivations and barriers.
    Kavookjian J; Mamidi S
    Clin Ther; 2008; 30 Pt 2():2241-9. PubMed ID: 19281918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study.
    Ariyo A; Hennekens CH; Stampfer MJ; Ridker PM
    J Cardiovasc Risk; 1998 Aug; 5(4):273-8. PubMed ID: 9919476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin after myocardial infarction: the importance of over-the-counter use.
    Hopper S; Pierce M
    Fam Pract; 1998 Apr; 15 Suppl 1():S10-3. PubMed ID: 9613460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey.
    Wong WM; Lim P; Wong BC
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S54-60. PubMed ID: 15324383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on aspirin in the primary prevention of cardiovascular disease.
    Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
    Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E; Pettersen KI; Landmark K; Reikvam A;
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician smoking status, attitudes toward smoking, and cessation advice to patients: an international survey.
    Pipe A; Sorensen M; Reid R
    Patient Educ Couns; 2009 Jan; 74(1):118-23. PubMed ID: 18774670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
    Short D; Frischer M; Bashford J; Ashcroft D
    BMC Fam Pract; 2003 Jul; 4():9. PubMed ID: 12871601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct].
    Di Pasquale G; Ottani F; Ceré E; Biancoli S; Sassone B; Lombardi A
    Recenti Prog Med; 1998 Oct; 89(10):514-9. PubMed ID: 9842255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
    So D; Cook EF; Le May M; Glover C; Williams W; Ha A; Davies R; Froeschl M; Marquis JF; O'Brien E; Labinaz M
    J Invasive Cardiol; 2009 Mar; 21(3):121-7. PubMed ID: 19258643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic- and anticoagulation regimens in OPCAB surgery. A Nordic survey.
    Hansen KH; Hughes P; Steinbrüchel DA
    Scand Cardiovasc J; 2005 Dec; 39(6):369-74. PubMed ID: 16352490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.